tiprankstipranks
Cytek Biosciences price target lowered to $15 from $18 at Piper Sandler
The Fly

Cytek Biosciences price target lowered to $15 from $18 at Piper Sandler

Piper Sandler analyst David Westenberg lowered the firm’s price target on Cytek Biosciences to $15 from $18 and keeps an Overweight rating on the shares. The analyst updated the model to reflect the company’s recent earnings report.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on CTKB:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles